PGF
AZN icon

Plan Group Financial’s AstraZeneca AZN Stock Holding History

Plan Group Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$369K Sell
1,871
-751
-29% -$145K 0.09% 145
2025
Q4 		$482K Buy
+2,622
New +$460K 0.13% 121

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Plan Group Financial's AZN Position: Q1 2026 in Review

Plan Group Financial reduced its AstraZeneca (AZN) stake by 29% in Q1 2026, selling an estimated $145K and leaving 1,871 shares worth $369K. The position accounts for 0.09% of the portfolio, ranked #145.

Plan Group Financial first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. The position peaked at $482K in Q4 2025. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Plan Group Financial held 1,871 shares of AstraZeneca worth $369K as of Q1 2026.
  • Plan Group Financial sold 751 AstraZeneca shares in Q1 2026, an estimated $145K.
  • AstraZeneca made up 0.09% of Plan Group Financial's portfolio in Q1 2026, its #145 holding.
  • Plan Group Financial first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
  • Plan Group Financial's AstraZeneca position peaked at $482K in Q4 2025.
  • 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Plan Group Financial's 13F filing for Q1 2026, filed 13 Apr 2026.